Simbrinza
My Prescription
Payment
Select pharmacy
$215.10
$15.00 due at pharmacy
$215.10 - $15.00 = $200.10
$200.10 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
WalmartPowered by$215.10
Print or send this coupon to your phone
WalmartPowered byAbout Simbrinza
Drug Details
Simbrinza is a prescription eye drop combining two medications, brinzolamide and brimonidine, designed to treat elevated eye pressure caused by open-angle glaucoma or ocular hypertension. By reducing fluid production in the eye, this medication helps lower the risk of vision impairment, nerve damage, or blindness. Brinzolamide, a carbonic anhydrase inhibitor, and brimonidine, an alpha-2 agonist, work synergistically to decrease intraocular pressure. Typically administered as one drop in the affected eye(s) three times daily, Simbrinza is not yet available in a generic form. Common side effects may include eye irritation, blurry vision, and altered taste. It is not recommended for children under two years due to potential severe side effects like significantly slowed breathing. Always consult your healthcare provider for personalized medical advice before starting any new treatment.
Price history for Simbrinza
1 Bottle, 8ML of 1-0.2%
Average retail price for Simbrinza
Average SaveHealth price for Simbrinza
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Simbrinza dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 8ML of 1-0.2% | 1 Bottle | $215.10 | $215.10 |
| 8ML of 1-0.2% | 2 Bottles | $425.19 | $212.60 |
| 8ML of 1-0.2% | 3 Bottles | $635.29 | $211.76 |
Simbrinza FAQs
Simbrinza is used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
The generic drugs for Simbrinza are brinzolamide and brimonidine tartrate.
Simbrinza can be expensive due to several factors, including the costs associated with research and development, manufacturing, and distribution. Additionally, it is a combination medication used for specific eye conditions, which can contribute to its pricing. The lack of generic alternatives and the costs of regulatory compliance may also play a role in its price. Patients are encouraged to discuss with their healthcare provider or pharmacist about potential cost-saving options, such as patient assistance programs or generic alternatives if available.
A substitute for Simbrinza, which is used to lower intraocular pressure in patients with glaucoma or ocular hypertension, could be other medications that serve a similar purpose. These may include other combination eye drops or individual medications such as beta-blockers (e.g., Timolol), prostaglandin analogs (e.g., Latanoprost), or carbonic anhydrase inhibitors (e.g., Dorzolamide). It is important for the patient to consult with an ophthalmologist to determine the most appropriate alternative based on their specific condition and medical history.
As of the latest available information, there is no specific date announced for when Simbrinza will become available as a generic medication. The availability of a generic version depends on patent expirations and regulatory approvals. It is advisable to check with a healthcare provider or a pharmacist for the most current information regarding the availability of generic Simbrinza.